ArticleAging2020

Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis.

Hao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.